NewYork-Presbyterian cancer specialists are at the forefront of expanding and innovating treatment for everything from breast cancer to glioblastoma. In 2025, our physicians and researchers from Columbia and Weill Cornell Medicine improved progression-free survival for multiple types of cancer, employed artificial intelligence to inform clinical care, discovered biomarkers that predict treatment responses to help personalize care in complex cases, and more. These advancements are breaking ground for new solutions that can improve cancer outcomes for all patients.
Through two world-class cancer centers – Columbia’s NCI-designated Herbert Irving Comprehensive Cancer Center and Weill Cornell Medicine’s Meyer Cancer Center, our team of physician-scientists are transforming care for cancer patients across a broad spectrum of malignant diseases and conditions. From pursuing novel laboratory research to better predict, diagnose and treat cancer, to conducting clinical trials of promising new therapies, our physicians provide personalized treatment plans to deliver optimal outcomes.
Oncology (Cancer)
Stay up to date with the latest in Oncology
The NYP Advances newsletter delivers groundbreaking research and advancements straight to your inbox.
Featured Updates
TransplantHow a Complex Partial Liver Transplant Saved a Two-Month Old Infant
How a Complex Partial Liver Transplant Saved a Two-Month Old Infant
On this episode of Advances in Care, Dr. Steven Lobritto, pediatric medical director for liver transplant at NewYork-Presbyterian and Columbia, joins host Erin Welsh to tell the story of a high-risk pediatric liver transplant that he and his team performed to save the life of a two month old baby, after the center where the baby was originally treated deemed her inoperable.
Podcast
Episode 49
The Latest
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
